This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies
- Comparison of Outcomes After 123I Versus 131I Preablation Imaging Before Radioiodine Ablation in Differentiated Thyroid Carcinoma
- Stunning Effect
- The So-Called Stunning of Thyroid Tissue
- Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
- A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments
- Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients
- Impact of 131I Diagnostic Activities on the Biokinetics of Thyroid Remnants
- Increasing Efficacy and Safety of Treatments of Patients with Well-Differentiated Thyroid Carcinoma by Measuring Body Retentions of 131I
- Treatment of Thyroid Carcinoma: Emphasis on High-Dose 131I Outpatient Therapy
- A Retrospective Review of the Effectiveness of Recombinant Human TSH as a Preparation for Radioiodine Thyroid Remnant Ablation
- Is Thyroid Stunning a Real Phenomenon or Just Fiction?
- Stunning of Iodide Transport by 131I Irradiation in Cultured Thyroid Epithelial Cells
- Stunning After Tracer Dosimetry
- Effect of a Diagnostic Dose of 185 MBq 131I on Postsurgical Thyroid Remnants